Cargando…

Stroke and diabetic ketoacidosis – some diagnostic and therapeutic considerations

Cerebrovascular insult (CVI) is a known and important risk factor for the development of diabetic ketoacidosis (DKA); still, it seems that the prevalence of DKA among the patients suffering CVI and its influence on stroke outcome might be underestimated. Diabetic ketoacidosis itself has been reporte...

Descripción completa

Detalles Bibliográficos
Autores principales: Jovanovic, Aleksandar, Stolic, Radojica V, Rasic, Dragisa V, Markovic-Jovanovic, Snezana R, Peric, Vladan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986295/
https://www.ncbi.nlm.nih.gov/pubmed/24748799
http://dx.doi.org/10.2147/VHRM.S59593
_version_ 1782311689335603200
author Jovanovic, Aleksandar
Stolic, Radojica V
Rasic, Dragisa V
Markovic-Jovanovic, Snezana R
Peric, Vladan M
author_facet Jovanovic, Aleksandar
Stolic, Radojica V
Rasic, Dragisa V
Markovic-Jovanovic, Snezana R
Peric, Vladan M
author_sort Jovanovic, Aleksandar
collection PubMed
description Cerebrovascular insult (CVI) is a known and important risk factor for the development of diabetic ketoacidosis (DKA); still, it seems that the prevalence of DKA among the patients suffering CVI and its influence on stroke outcome might be underestimated. Diabetic ketoacidosis itself has been reported to be a risk factor for the occurrence of stroke in children and youth. A cerebral hypoperfusion in untreated DKA may lead to cerebral injury, arterial ischemic stroke, cerebral venous thrombosis, and hemorrhagic stroke. All these were noted following DKA episodes in children. At least some of these mechanisms may be operative in adults and complicate the course and outcome of CVI. There is a considerable overlap of symptoms, signs, and laboratory findings in the two conditions, making their interpretation difficult, particularly in the elderly and less communicative patients. Serum pH and bicarbonate, blood gases, and anion gap levels should be routinely measured in all type 1 and type 2 diabetics, regardless of symptomatology, for the early detection of existing or pending ketoacidosis. The capacity for rehydration in patients with stroke is limited, and the treatment of the cerebrovascular disease requires intensive use of osmotic and loop diuretics. Fluid repletion may be difficult, and the precise management algorithms are required. Intravenous insulin is the backbone of treatment, although its effect may be diminished due to delayed fluid replenishment. Therefore, the clinical course of diabetic ketoacidosis in patients with CVI may be prolonged and complicated.
format Online
Article
Text
id pubmed-3986295
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-39862952014-04-18 Stroke and diabetic ketoacidosis – some diagnostic and therapeutic considerations Jovanovic, Aleksandar Stolic, Radojica V Rasic, Dragisa V Markovic-Jovanovic, Snezana R Peric, Vladan M Vasc Health Risk Manag Mini-Review Cerebrovascular insult (CVI) is a known and important risk factor for the development of diabetic ketoacidosis (DKA); still, it seems that the prevalence of DKA among the patients suffering CVI and its influence on stroke outcome might be underestimated. Diabetic ketoacidosis itself has been reported to be a risk factor for the occurrence of stroke in children and youth. A cerebral hypoperfusion in untreated DKA may lead to cerebral injury, arterial ischemic stroke, cerebral venous thrombosis, and hemorrhagic stroke. All these were noted following DKA episodes in children. At least some of these mechanisms may be operative in adults and complicate the course and outcome of CVI. There is a considerable overlap of symptoms, signs, and laboratory findings in the two conditions, making their interpretation difficult, particularly in the elderly and less communicative patients. Serum pH and bicarbonate, blood gases, and anion gap levels should be routinely measured in all type 1 and type 2 diabetics, regardless of symptomatology, for the early detection of existing or pending ketoacidosis. The capacity for rehydration in patients with stroke is limited, and the treatment of the cerebrovascular disease requires intensive use of osmotic and loop diuretics. Fluid repletion may be difficult, and the precise management algorithms are required. Intravenous insulin is the backbone of treatment, although its effect may be diminished due to delayed fluid replenishment. Therefore, the clinical course of diabetic ketoacidosis in patients with CVI may be prolonged and complicated. Dove Medical Press 2014-04-08 /pmc/articles/PMC3986295/ /pubmed/24748799 http://dx.doi.org/10.2147/VHRM.S59593 Text en © 2014 Jovanovic et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Mini-Review
Jovanovic, Aleksandar
Stolic, Radojica V
Rasic, Dragisa V
Markovic-Jovanovic, Snezana R
Peric, Vladan M
Stroke and diabetic ketoacidosis – some diagnostic and therapeutic considerations
title Stroke and diabetic ketoacidosis – some diagnostic and therapeutic considerations
title_full Stroke and diabetic ketoacidosis – some diagnostic and therapeutic considerations
title_fullStr Stroke and diabetic ketoacidosis – some diagnostic and therapeutic considerations
title_full_unstemmed Stroke and diabetic ketoacidosis – some diagnostic and therapeutic considerations
title_short Stroke and diabetic ketoacidosis – some diagnostic and therapeutic considerations
title_sort stroke and diabetic ketoacidosis – some diagnostic and therapeutic considerations
topic Mini-Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986295/
https://www.ncbi.nlm.nih.gov/pubmed/24748799
http://dx.doi.org/10.2147/VHRM.S59593
work_keys_str_mv AT jovanovicaleksandar strokeanddiabeticketoacidosissomediagnosticandtherapeuticconsiderations
AT stolicradojicav strokeanddiabeticketoacidosissomediagnosticandtherapeuticconsiderations
AT rasicdragisav strokeanddiabeticketoacidosissomediagnosticandtherapeuticconsiderations
AT markovicjovanovicsnezanar strokeanddiabeticketoacidosissomediagnosticandtherapeuticconsiderations
AT pericvladanm strokeanddiabeticketoacidosissomediagnosticandtherapeuticconsiderations